Pavel Mozgunov
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy.
Journal: Statistical methods in medical research
Published: September 02, 2026
Adaptive versus fixed designs in confirmatory clinical trials: centering the choice on ethics.
Journal: Clinical trials (London, England)
Published: August 04, 2026
Adaptive versus fixed designs in confirmatory clinical trials: centering the choice on ethics.
Journal: Clinical trials (London, England)
Published: August 04, 2026
An evaluation of designs for Phase I/IIa dose-finding studies in Tuberculosis.
Journal: Statistical methods in medical research
Published: June 01, 2026
Adaptive Trial Designs for Assessing Predictiveness of a Biomarker in Early Phase Drug Development.
Journal: Statistics in medicine
Published: February 02, 2026
Early Phase Dose-Finding Designs for CAR-T Cell Therapies.
Journal: Pharmaceutical statistics
Published: December 01, 2025
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.
Journal: The Journal of antimicrobial chemotherapy
Published: November 19, 2025
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.
Journal: Clinical pharmacology and therapeutics
Published: October 08, 2025
A Novel Method for Inserting Dose Levels Mid-Trial in Early-Phase Oncology Combination Studies.
Journal: Statistics in medicine
Published: July 17, 2025
Seamless monotherapy-combination phase I dose-escalation model-based design.
Journal: Clinical trials (London, England)
Published: July 12, 2025
On the Interplay Between Prior Weight and Variance of the Robustification Component in Robust Mixture Prior Bayesian Dynamic Borrowing Approach.
Journal: Statistics in medicine
Published: July 02, 2025
Using circulating tumor DNA as a novel biomarker of efficacy for dose-finding designs in oncology.
Journal: Statistical methods in medical research
Published: July 01, 2025
Last Updated: 09/26/2026